Recommended Medications for Constipation in Pregnancy
For constipation in pregnancy, start with dietary fiber (30 g/day), then use polyethylene glycol (PEG) or lactulose as first-line pharmacological therapy, with PEG preferred due to fewer side effects like bloating and diarrhea. 1
Stepwise Treatment Approach
First-Line: Non-Pharmacological
- Increase dietary fiber to approximately 30 g/day through fruits, vegetables, whole grains, and legumes
- Ensure adequate fluid intake, particularly water
- These measures are safe throughout all trimesters due to lack of systemic absorption 1
Second-Line: Bulk-Forming Agents
If dietary modifications are insufficient:
- Psyllium husk or methylcellulose are safe options
- Soluble fiber (psyllium) is superior to insoluble fiber as it improves both stool viscosity and transit time
- Ensure adequate hydration as fiber intake increases 1
Common pitfall: Excessive fiber can cause maternal bloating, so titrate gradually based on tolerance.
Third-Line: Osmotic Laxatives (Primary Pharmacological Options)
Polyethylene Glycol (PEG) 4000:
- Dose: 10-17 g daily
- Advantages: Faster onset of action, fewer side effects (less bloating, flatulence, diarrhea, and loose stools compared to lactulose) 2, 3, 4
- Safe throughout pregnancy with no systemic absorption
- Recent high-quality RCT (2024) showed 86.3% achieved complete spontaneous bowel movements 2
Lactulose:
- Dose: 10-15 g daily
- Advantages: Only osmotic agent specifically studied in pregnancy 5
- Effective but associated with more bloating and flatulence, which may be limiting 1, 2
- Recent RCT showed 82.9% achieved complete spontaneous bowel movements 2
Clinical reasoning: While both PEG and lactulose are effective and safe, PEG demonstrates superior tolerability with significantly less diarrhea and loose stools after adjusted analysis 2. The 2024 AGA guideline explicitly lists both as safe treatment options 1.
Medications to AVOID
Stimulant laxatives (bisacodyl, senna, picosulfate):
- Should be avoided due to conflicting safety data in pregnancy 1
- Risk of tenesmus (straining) may be associated with preterm births 6
- Reserve only for severe cases in second/third trimester if osmotic laxatives fail, and only after careful risk-benefit discussion
Magnesium oxide:
- Use with caution in pregnancy due to potential renal concerns 5
Evidence Quality
The recommendations are based on:
- 2024 AGA Clinical Practice Update (highest quality, most recent guideline) providing explicit Best Practice Advice 1
- 2024 RCT (n=247) directly comparing PEG vs lactulose in pregnant women at 28-32 weeks gestation 2
- 2024 prospective cohort (n=211) confirming PEG safety and efficacy without inducing diarrhea 3
Practical Implementation
- Start with lifestyle: 30 g fiber/day + adequate hydration
- Add bulk-forming agent if needed: Psyllium husk with water
- Escalate to osmotic laxative: PEG 10 g daily (preferred) or lactulose 10-15 g daily
- Titrate dose based on symptom response and side effects
- Avoid stimulant laxatives unless absolutely necessary in 2nd/3rd trimester
Key caveat: Constipation affects 20-40% of pregnant women due to progesterone-induced decreased GI motility, so treatment is often necessary and should not be delayed 1. Encourage patients to avoid straining during bowel movements through adequate time, relaxation techniques, and the above interventions.